{"id":40411,"date":"2017-10-25T08:39:42","date_gmt":"2017-10-25T12:39:42","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=40411"},"modified":"2017-10-25T00:40:38","modified_gmt":"2017-10-25T04:40:38","slug":"what-is-going-on-with-atossa-genetics-inc-nasdaqatos","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411","title":{"rendered":"What Is Going On With Atossa Genetics Inc (NASDAQ:ATOS)?"},"content":{"rendered":"

Atossa Genetics Inc (NASDAQ:ATOS)<\/strong> a clinical-stage pharmaceutical firm developing novel delivery methods and therapeutics for breast cancer and other breast problems, reported that the Ernest Mario School of Pharmacy at Rutgers, intends to plan a study using company\u2019s intraductal microcatheter technology.<\/p>\n

The details<\/strong><\/p>\n

The Rutgers researchers consider that directly administering medications into the breast duct, by putting microcatheters into the nipple, marks as a better option than systemic administration, as the medications will be directly administered to the tissue. The Rutgers plan utilizes an innovative directed delivery mechanism constituted of nanoscale pharmaceutical carriers full of single drugs. The long-term objective of the research plan is to advance a locally administered drug delivery mechanism that selectively targets and offers pathway-specific targeting therapeutics to remove cancer stem-like cells and breast cancer cells while sparing normal breast cells.<\/p>\n

Steven Quay, MD, PhD, the President and CEO of Atossa, expressed that they are thrilled that a major research institution such as Rutgers understands the prospective advantage of their microcatheter technology. The company entirely supports additional research using their patented microcatheter technology.<\/p>\n

The Rutgers plan is in the research and development stage and has not been permitted by the FDA or any other regulatory firm. Studies demonstrating efficacy and safety, among other things, and regulatory nods will be needed before commercialization.<\/p>\n

Earlier Atossa reported that a new program utilizing Chimeric Antigen Receptor Therapy, it intends to utilize its intraductal microcatheter technology to offer CAR-T cells into the breast ducts for the prospective intended treatment of breast cancer.<\/p>\n

The company\u2019s novel approach utilizes its intraductal microcatheter know-how for the potential transpapillary, for T-cells delivery that have been genetically changed to attack breast cancer cells. Atossa considers this method has numerous potential advantages: lowered toxicity by confining systemic exposure of the T-cells; enhanced efficacy by putting the T-cells in direct contact with the aimed ductal epithelial cells that are facing malignant transformation; and others.<\/p>\n","protected":false},"excerpt":{"rendered":"

Atossa Genetics Inc (NASDAQ:ATOS) a clinical-stage pharmaceutical firm developing novel delivery methods and therapeutics for breast cancer and other breast problems, reported that the Ernest […]<\/p>\n","protected":false},"author":6,"featured_media":16500,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[3289,2519,2520],"stock_ticker":[],"class_list":["post-40411","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-atossa-genetics-inc","tag-atossa-genetics-inc-nasdaqatos","tag-nasdaqatos","entry"],"acf":[],"yoast_head":"\nWhat Is Going On With Atossa Genetics Inc (NASDAQ:ATOS)? - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"What Is Going On With Atossa Genetics Inc (NASDAQ:ATOS)? - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Atossa Genetics Inc (NASDAQ:ATOS) a clinical-stage pharmaceutical firm developing novel delivery methods and therapeutics for breast cancer and other breast problems, reported that the Ernest […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-10-25T12:39:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Atossa-Genetics-Inc.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"576\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Brendan Byrne\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brendan Byrne\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411\"},\"author\":{\"name\":\"Brendan Byrne\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/63a75bf2d685d9d351a6f01cfc69b511\"},\"headline\":\"What Is Going On With Atossa Genetics Inc (NASDAQ:ATOS)?\",\"datePublished\":\"2017-10-25T12:39:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411\"},\"wordCount\":330,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Atossa-Genetics-Inc.jpg\",\"keywords\":[\"Atossa Genetics Inc\",\"Atossa Genetics Inc. (NASDAQ:ATOS)\",\"NASDAQ:ATOS\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411\",\"name\":\"What Is Going On With Atossa Genetics Inc (NASDAQ:ATOS)? - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Atossa-Genetics-Inc.jpg\",\"datePublished\":\"2017-10-25T12:39:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Atossa-Genetics-Inc.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Atossa-Genetics-Inc.jpg\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"What Is Going On With Atossa Genetics Inc (NASDAQ:ATOS)?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/63a75bf2d685d9d351a6f01cfc69b511\",\"name\":\"Brendan Byrne\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c07a17b7438044417a1ad0f7933a311fcc2a96eaf4b15f2599b0fdfb37cbda41?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c07a17b7438044417a1ad0f7933a311fcc2a96eaf4b15f2599b0fdfb37cbda41?s=96&d=mm&r=g\",\"caption\":\"Brendan Byrne\"},\"description\":\"While studying economics, Brendan found himself comfortably falling down the rabbit hole of restaurant work, ultimately opening a consulting business and working as a private wine buyer. On a whim, he moved to China, and in his first week following a triumphant pub quiz victory, he found himself bleeding on the floor based on his arrogance. The same man who put him there offered him a job lecturing for the University of Wales in various sister universities throughout the Middle Kingdom. While primarily lecturing in descriptive and comparative statistics, Brendan simultaneously earned an Msc in Banking and International Finance from the University of Wales-Bangor. He's presently doing something he hates, respecting French people. Well, two, his wife and her mother in the lovely town of Antigua, Guatemala. You may contact Brendan via his email (brendanbyrne@cablemanpro.com) or his Google+ page (https:\/\/plus.google.com\/u\/0\/116608759701551457422).\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/brendan-byrne\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"What Is Going On With Atossa Genetics Inc (NASDAQ:ATOS)? - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411","og_locale":"en_US","og_type":"article","og_title":"What Is Going On With Atossa Genetics Inc (NASDAQ:ATOS)? - Wall Street PR","og_description":"Atossa Genetics Inc (NASDAQ:ATOS) a clinical-stage pharmaceutical firm developing novel delivery methods and therapeutics for breast cancer and other breast problems, reported that the Ernest […]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2017-10-25T12:39:42+00:00","og_image":[{"width":1024,"height":576,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Atossa-Genetics-Inc.jpg","type":"image\/jpeg"}],"author":"Brendan Byrne","twitter_misc":{"Written by":"Brendan Byrne","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411"},"author":{"name":"Brendan Byrne","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/63a75bf2d685d9d351a6f01cfc69b511"},"headline":"What Is Going On With Atossa Genetics Inc (NASDAQ:ATOS)?","datePublished":"2017-10-25T12:39:42+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411"},"wordCount":330,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Atossa-Genetics-Inc.jpg","keywords":["Atossa Genetics Inc","Atossa Genetics Inc. (NASDAQ:ATOS)","NASDAQ:ATOS"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411","url":"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411","name":"What Is Going On With Atossa Genetics Inc (NASDAQ:ATOS)? - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Atossa-Genetics-Inc.jpg","datePublished":"2017-10-25T12:39:42+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Atossa-Genetics-Inc.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Atossa-Genetics-Inc.jpg","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/what-is-going-on-with-atossa-genetics-inc-nasdaqatos-40411#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"What Is Going On With Atossa Genetics Inc (NASDAQ:ATOS)?"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/63a75bf2d685d9d351a6f01cfc69b511","name":"Brendan Byrne","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/c07a17b7438044417a1ad0f7933a311fcc2a96eaf4b15f2599b0fdfb37cbda41?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c07a17b7438044417a1ad0f7933a311fcc2a96eaf4b15f2599b0fdfb37cbda41?s=96&d=mm&r=g","caption":"Brendan Byrne"},"description":"While studying economics, Brendan found himself comfortably falling down the rabbit hole of restaurant work, ultimately opening a consulting business and working as a private wine buyer. On a whim, he moved to China, and in his first week following a triumphant pub quiz victory, he found himself bleeding on the floor based on his arrogance. The same man who put him there offered him a job lecturing for the University of Wales in various sister universities throughout the Middle Kingdom. While primarily lecturing in descriptive and comparative statistics, Brendan simultaneously earned an Msc in Banking and International Finance from the University of Wales-Bangor. He's presently doing something he hates, respecting French people. Well, two, his wife and her mother in the lovely town of Antigua, Guatemala. You may contact Brendan via his email (brendanbyrne@cablemanpro.com) or his Google+ page (https:\/\/plus.google.com\/u\/0\/116608759701551457422).","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/brendan-byrne"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/40411","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=40411"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/40411\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/16500"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=40411"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=40411"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=40411"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=40411"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}